Johnson & Johnson: Tracking Well Above The Industry
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
FiercePharma18h
AstraZeneca and Merck's Koselugo delivers phase 3 trial win in adults with NF1, teeing up filings
The KOMET trial, the largest global placebo-controlled trial in the patient group ... The drug is approved in more than 55 ...
Business Insider21h
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
About the 4WARD Global, Pivotal, Phase 3 Clinical Trial The 4WARD trial ... X4 may have difficulty establishing and maintaining an effective sales and marketing organization or suitable third-party ...